GeoVax Labs GOVX
NASDAQ GOVX
$0.33 -0.02 (-5.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

GeoVax Labs (GOVX) Short term Debt (2020)

Updated

GeoVax Labs (GOVX) posted Short term Debt of $435,711 for Q2 2020.

Analysis

GeoVax Labs (GOVX) Short term Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 GeoVax Labs 1.60 Mn -12.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 435,711.00
API Access

GeoVax Labs Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=GOVX&period=max&api_key=YOUR_API_KEY